Monica M. Farley

40.3k total citations · 16 hit papers
235 papers, 28.0k citations indexed

About

Monica M. Farley is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Monica M. Farley has authored 235 papers receiving a total of 28.0k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Epidemiology, 80 papers in Infectious Diseases and 63 papers in Microbiology. Recurrent topics in Monica M. Farley's work include Pneumonia and Respiratory Infections (114 papers), Bacterial Infections and Vaccines (61 papers) and Respiratory viral infections research (57 papers). Monica M. Farley is often cited by papers focused on Pneumonia and Respiratory Infections (114 papers), Bacterial Infections and Vaccines (61 papers) and Respiratory viral infections research (57 papers). Monica M. Farley collaborates with scholars based in United States, Uganda and Canada. Monica M. Farley's co-authors include Lee H. Harrison, Arthur Reingold, Anne Schuchat, Ruth Lynfield, Cynthia G. Whitney, James L. Hadler, William Schaffner, Nancy M. Bennett, Ann Thomas and Paul R. Cieslak and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Monica M. Farley

227 papers receiving 27.0k citations

Hit Papers

Burden of Clostridium difficil... 1997 2026 2006 2016 2015 2003 2005 2009 1997 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Burden of Clostridium difficile Infection in the United States
    2015 2.0k citations Fernanda C. Lessa, Yi Mu et al. New England Journal of Medicine profile →
  2. Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
    2003 1.7k citations Cynthia G. Whitney, Monica M. Farley et al. New England Journal of Medicine profile →
  3. Methicillin-ResistantStaphylococcus aureusDisease in Three Communities
    2005 1.2k citations Scott K. Fridkin, Lee H. Harrison et al. New England Journal of Medicine profile →
  4. Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
    2009 1.0k citations Tamara Pilishvili, Monica M. Farley et al. profile →
  5. Bacterial Meningitis in the United States in 1995
    1997 934 citations Anne Schuchat, Jay D. Wenger et al. New England Journal of Medicine profile →
  6. Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis
    2000 759 citations Stephanie J. Schrag, Monica M. Farley et al. New England Journal of Medicine profile →
  7. Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United States
    2000 691 citations Cynthia G. Whitney, Monica M. Farley et al. New England Journal of Medicine profile →
  8. Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae
    2006 653 citations Ruth Lynfield, William Schaffner et al. New England Journal of Medicine profile →
  9. Bacterial Meningitis in the United States, 1998–2007
    2011 632 citations Cynthia G. Whitney, Elizabeth R. Zell et al. New England Journal of Medicine profile →
  10. Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004
    2007 609 citations Lee H. Harrison, James L. Hadler et al. profile →
  11. Cigarette Smoking and Invasive Pneumococcal Disease
    2000 578 citations J. Pekka Nuorti, Monica M. Farley et al. New England Journal of Medicine profile →
  12. Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes
    2020 529 citations Alice Guh, Yi Mu et al. New England Journal of Medicine profile →
  13. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
    2006 503 citations Cynthia G. Whitney, Monica M. Farley et al. The Lancet profile →
  14. Active Bacterial Core Surveillance of the Emerging Infections Program Network
    2001 501 citations Anne Schuchat, Elizabeth R. Zell et al. profile →
  15. Epidemiology of Invasive Early-Onset Neonatal Sepsis, 2005 to 2014
    2016 300 citations Stephanie J. Schrag, Monica M. Farley et al. PEDIATRICS profile →
  16. Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015
    2019 254 citations Susan Petit, Mirasol Apostol et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monica M. Farley United States 79 18.8k 9.4k 7.2k 6.8k 1.9k 235 28.0k
Lee H. Harrison United States 85 19.7k 1.0× 10.0k 1.1× 6.0k 0.8× 8.7k 1.3× 2.0k 1.1× 389 29.9k
Ruth Lynfield United States 59 10.8k 0.6× 5.8k 0.6× 5.0k 0.7× 3.3k 0.5× 1.7k 0.9× 274 19.2k
Richard R. Facklam United States 69 10.7k 0.6× 5.9k 0.6× 7.2k 1.0× 4.2k 0.6× 1.8k 0.9× 239 18.6k
Jack D. Sobel United States 81 18.8k 1.0× 16.2k 1.7× 1.9k 0.3× 9.2k 1.4× 3.0k 1.6× 431 30.4k
Keith P. Klugman United States 79 18.5k 1.0× 4.2k 0.4× 2.7k 0.4× 6.6k 1.0× 1.6k 0.8× 395 25.0k
Sheldon L. Kaplan United States 69 11.1k 0.6× 11.3k 1.2× 7.5k 1.0× 5.2k 0.8× 2.3k 1.2× 361 26.0k
Daniel M. Musher United States 75 17.3k 0.9× 6.9k 0.7× 2.9k 0.4× 3.2k 0.5× 1.7k 0.9× 340 26.9k
Walter E. Stamm United States 90 17.1k 0.9× 4.2k 0.4× 1.6k 0.2× 8.8k 1.3× 2.6k 1.4× 337 27.3k
Arnold S. Bayer United States 82 10.6k 0.6× 16.3k 1.7× 7.1k 1.0× 3.4k 0.5× 7.5k 3.9× 372 27.7k
Derrick W. Crook United Kingdom 79 9.0k 0.5× 8.7k 0.9× 2.2k 0.3× 2.8k 0.4× 4.9k 2.6× 328 21.7k

Countries citing papers authored by Monica M. Farley

Since Specialization
Citations

This map shows the geographic impact of Monica M. Farley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica M. Farley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica M. Farley more than expected).

Fields of papers citing papers by Monica M. Farley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica M. Farley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica M. Farley. The network helps show where Monica M. Farley may publish in the future.

Co-authorship network of co-authors of Monica M. Farley

This figure shows the co-authorship network connecting the top 25 collaborators of Monica M. Farley. A scholar is included among the top collaborators of Monica M. Farley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica M. Farley. Monica M. Farley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Misas, Elizabeth, Lucy S Witt, Monica M. Farley, et al.. (2024). Molecular and Epidemiological Investigation of Fluconazole-resistant Candida parapsilosis—Georgia, United States, 2021. Open Forum Infectious Diseases. 11(6). ofae264–ofae264. 8 indexed citations
4.
Pilishvili, Tamara, Ryan Gierke, Monica M. Farley, et al.. (2020). 1470. Epidemiology of Invasive Pneumococcal Disease (IPD) Following 18 years of Pneumococcal Conjugate Vaccine (PCV) Use in the United States. Open Forum Infectious Diseases. 7(Supplement_1). S736–S737. 14 indexed citations
5.
Chande, Aroon T., Eileen M. Burd, Victor I. Band, et al.. (2020). Absence of mgrB Alleviates Negative Growth Effects of Colistin Resistance in Enterobacter cloacae. Antibiotics. 9(11). 825–825. 5 indexed citations
6.
Guh, Alice, Yi Mu, James Baggs, et al.. (2018). Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015. American Journal of Infection Control. 46(7). 840–842. 17 indexed citations
7.
Lessa, Fernanda C., Yi Mu, Wendy Bamberg, et al.. (2015). Burden of Clostridium difficile Infection in the United States. New England Journal of Medicine. 372(9). 825–834. 2007 indexed citations breakdown →
8.
MacNeil, Jessica R., Nancy M. Bennett, Monica M. Farley, et al.. (2015). Epidemiology of Infant Meningococcal Disease in the United States, 2006-2012. PEDIATRICS. 135(2). e305–e311. 32 indexed citations
9.
Chancey, Scott, et al.. (2015). Composite mobile genetic elements disseminating macrolide resistance in Streptococcus pneumoniae. Frontiers in Microbiology. 6. 26–26. 52 indexed citations
10.
Sharma, Dolly, Emily K. Crispell, Wendy Baughman, et al.. (2015). Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia. The Pediatric Infectious Disease Journal. 34(11). 1168–1174. 95 indexed citations
11.
Spicer, Jennifer O., et al.. (2013). Socioeconomic and Racial Disparities of Pediatric Invasive Pneumococcal Disease After the Introduction of the 7-valent Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal. 33(2). 158–164. 12 indexed citations
12.
Sharma, Dolly, Wendy Baughman, Stephanie Thomas, et al.. (2012). Pneumococcal Carriage and Invasive Disease in Children Before Introduction of the 13-valent Conjugate Vaccine. The Pediatric Infectious Disease Journal. 32(2). e45–e53. 68 indexed citations
13.
Weston, Emily, Tracy Pondo, Melissa Lewis, et al.. (2011). The Burden of Invasive Early-onset Neonatal Sepsis in the United States, 2005–2008. The Pediatric Infectious Disease Journal. 30(11). 937–941. 373 indexed citations
14.
Iqbal, Naureen, et al.. (2010). FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance. Antimicrobial Agents and Chemotherapy. 54(12). 5042–5047. 109 indexed citations
15.
Jordan, Hannah, Monica M. Farley, Allen S. Craig, et al.. (2008). Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease. The Pediatric Infectious Disease Journal. 27(12). 1057–1064. 145 indexed citations
16.
O’Brien, Katherine L., Orin S. Levine, Cynthia G. Whitney, et al.. (2006). Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.(Clinical report). The Lancet. 368(9546). 61 indexed citations
17.
Stephens, David S., Susu M. Zughaier, Cynthia G. Whitney, et al.. (2005). Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. The Lancet. 365(9462). 855–863. 133 indexed citations
18.
Schuchat, Anne, Elizabeth R. Zell, Monica M. Farley, et al.. (2001). Active Bacterial Core Surveillance of the Emerging Infections Program Network. SHILAP Revista de lepidopterología. 12 indexed citations
19.
Schrag, Stephanie J., Monica M. Farley, Arthur Reingold, et al.. (2000). Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis. Obstetrical & Gynecological Survey. 55(6). 345–346. 42 indexed citations
20.
Farley, Monica M., et al.. (1992). Invasive Haemophilus influenzae Disease in Adults. Annals of Internal Medicine. 116(10). 806–812. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lee H. Harrison Breakdown of academic impact, for papers by Ruth Lynfield Breakdown of academic impact, for papers by Richard R. Facklam Breakdown of academic impact, for papers by Jack D. Sobel Breakdown of academic impact, for papers by Keith P. Klugman Breakdown of academic impact, for papers by Sheldon L. Kaplan Breakdown of academic impact, for papers by Daniel M. Musher Breakdown of academic impact, for papers by Walter E. Stamm Breakdown of academic impact, for papers by Arnold S. Bayer Breakdown of academic impact, for papers by Derrick W. Crook
Rankless by CCL
2026